Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys631
Sells11488
Buy $$21.95B
Sell $$16.40B
Ratio1.34:1
% Change vs. Prior
Ratio +97.8%Value +173.5%
Healthcare
Buys623
Sells4936
Buy $$453.57M
Sell $$11.65B
Ratio1:25.69
% Change vs. Prior
Ratio -37.3%Value -21.6%
Industrials
Buys400
Sells2078
Buy $$356.72M
Sell $$7.36B
Ratio1:20.62
% Change vs. Prior
Ratio +144.1%Value +35.8%
Consumer Cyclical
Buys366
Sells2043
Buy $$1.12B
Sell $$4.06B
Ratio1:3.62
% Change vs. Prior
Ratio +17.7%Value +74.8%
Financial Services
Buys1274
Sells2860
Buy $$672.67M
Sell $$4.08B
Ratio1:6.06
% Change vs. Prior
Ratio -17.1%Value -20.2%
Energy
Buys301
Sells436
Buy $$99.59M
Sell $$4.56B
Ratio1:45.84
% Change vs. Prior
Ratio +41.8%Value -17.7%
Consumer Defensive
Buys160
Sells738
Buy $$137.72M
Sell $$2.09B
Ratio1:15.15
% Change vs. Prior
Ratio +103.5%Value +22.7%
Utilities
Buys70
Sells288
Buy $$74.99M
Sell $$1.39B
Ratio1:18.48
% Change vs. Prior
Ratio +20812.0%Value -78.7%
Communication Services
Buys140
Sells880
Buy $$166.18M
Sell $$1.27B
Ratio1:7.62
% Change vs. Prior
Ratio +117.6%Value +37.9%
Basic Materials
Buys138
Sells263
Buy $$67.45M
Sell $$680.74M
Ratio1:10.09
% Change vs. Prior
Ratio -52.8%Value -25.4%
Real Estate
Buys190
Sells329
Buy $$36.93M
Sell $$264.73M
Ratio1:7.17
% Change vs. Prior
Ratio -54.4%Value -23.6%
By Industry
Hardware, Equipment & Parts
Buys24
Sells1318
Buy $$21.63B
Sell $$835.12M
Ratio25.90:1
% Change vs. Prior
Ratio +217.9%Value +290.9%
Software - Infrastructure
Buys54
Sells3881
Buy $$33.48M
Sell $$5.15B
Ratio1:153.80
% Change vs. Prior
Ratio -72.6%Value +172.4%
Medical - Instruments & Supplies
Buys37
Sells113
Buy $$16.33M
Sell $$3.67B
Ratio1:224.98
% Change vs. Prior
Ratio +21.6%Value -52.1%
Biotechnology
Buys375
Sells3369
Buy $$379.91M
Sell $$3.06B
Ratio1:8.06
% Change vs. Prior
Ratio -56.6%Value +25.9%
Semiconductors
Buys111
Sells1850
Buy $$2.67M
Sell $$3.29B
Ratio1:1234.04
% Change vs. Prior
Ratio -80.4%Value +23.9%
Oil & Gas Exploration & Production
Buys177
Sells88
Buy $$48.68M
Sell $$2.63B
Ratio1:54.00
% Change vs. Prior
Ratio +404.5%Value -23.7%
Software - Application
Buys357
Sells1721
Buy $$267.76M
Sell $$2.40B
Ratio1:8.98
% Change vs. Prior
Ratio -63.7%Value +50.6%
Engineering & Construction
Buys13
Sells238
Buy $$1.90M
Sell $$2.34B
Ratio1:1232.64
Computer Hardware
Buys3
Sells1720
Buy $$104.50K
Sell $$2.32B
Ratio1:22225.68
Medical - Healthcare Information Services
Buys30
Sells326
Buy $$8.45M
Sell $$2.11B
Ratio1:250.14
% Change vs. Prior
Ratio -76.3%Value +18.1%
Rental & Leasing Services
Buys7
Sells112
Buy $$2.92M
Sell $$1.87B
Ratio1:642.28
Specialty Retail
Buys83
Sells975
Buy $$24.13M
Sell $$1.63B
Ratio1:67.55
% Change vs. Prior
Ratio -87.0%Value -15.3%
Shell Companies
Buys102
Sells269
Buy $$107.99M
Sell $$1.32B
Ratio1:12.21
% Change vs. Prior
Ratio +38.8%Value +49.9%
Information Technology Services
Buys64
Sells240
Buy $$9.67M
Sell $$1.40B
Ratio1:144.68
Leisure
Buys29
Sells107
Buy $$7.63M
Sell $$1.29B
Ratio1:169.74
Transactions (26583)
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
240
Price
$311.65
Total Value
$74.80K
Shares Held After
1,378,155
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,039
Price
$310.94
Total Value
$634.00K
Shares Held After
1,378,395
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,801
Price
$309.95
Total Value
$868.16K
Shares Held After
1,380,434
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,803
Price
$308.89
Total Value
$1.17M
Shares Held After
1,383,235
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
12,729
Price
$307.81
Total Value
$3.92M
Shares Held After
1,387,038
% of Holdings
0.9%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,348
Price
$307.09
Total Value
$413.96K
Shares Held After
1,399,767
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
480
Price
$305.87
Total Value
$146.82K
Shares Held After
1,401,115
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
400
Price
$304.89
Total Value
$121.96K
Shares Held After
1,401,595
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
247
Price
$303.17
Total Value
$74.88K
Shares Held After
1,401,995
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
593
Price
$302.25
Total Value
$179.23K
Shares Held After
1,402,242
% of Holdings
0.0%
ICHOR HOLDINGS, LTD. (ICHR)
BARROS PHILIP RYAN SR. — Director
Shares
13,705
Price
$70.19
Total Value
$961.95K
Shares Held After
165,078
% of Holdings
7.7%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
320
Price
$300.75
Total Value
$96.24K
Shares Held After
1,402,835
% of Holdings
0.0%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
100
Price
$9.00
Total Value
$900.00
Shares Held After
875,459
% of Holdings
0.0%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
8,939
Price
$37.09
Total Value
$331.54K
Shares Held After
64,620
% of Holdings
12.2%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
7,000
Price
$36.51
Total Value
$255.56K
Shares Held After
73,559
% of Holdings
8.7%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
4,900
Price
$35.47
Total Value
$173.78K
Shares Held After
80,559
% of Holdings
5.7%
Pacira BioSciences, Inc. (PCRX)
WILLIAMS KRISTEN — Chief Administrative Officer
Shares
10,259
Price
$22.27
Total Value
$228.47K
Shares Held After
167,062
% of Holdings
5.8%
TJX COMPANIES INC /DE/ (TJX)
Herrman Ernie — Director
Shares
28,000
Price
$158.32
Total Value
$4.43M
Shares Held After
524,850
% of Holdings
5.1%
NovoCure Ltd (NVCR)
Leonard Frank X — Chief Executive Officer
Shares
34,273
Price
$17.93
Total Value
$614.63K
Shares Held After
459,520
% of Holdings
6.9%
California Resources Corp (CRC)
Bys Jay A. — EVP & Chief Commercial Officer
Shares
11,907
Price
$61.68
Total Value
$734.42K
Shares Held After
171,331
% of Holdings
6.5%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
1,000
Price
$12.80
Total Value
$12.80K
Shares Held After
21,969
% of Holdings
4.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$12.68
Total Value
$6.34K
Shares Held After
22,969
% of Holdings
2.1%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
1,000
Price
$54.50
Total Value
$54.50K
Shares Held After
0
% of Holdings
100.0%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
826
Price
$87.91
Total Value
$72.61K
Shares Held After
802,708
% of Holdings
0.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
8,581
Price
$87.13
Total Value
$747.66K
Shares Held After
803,534
% of Holdings
1.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
10,992
Price
$86.07
Total Value
$946.08K
Shares Held After
812,115
% of Holdings
1.3%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
17,543
Price
$85.11
Total Value
$1.49M
Shares Held After
823,107
% of Holdings
2.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
2,060
Price
$83.86
Total Value
$172.75K
Shares Held After
840,650
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$550.48
Total Value
$66.06K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,298
Price
$549.06
Total Value
$712.68K
Shares Held After
18,996
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,749
Price
$548.04
Total Value
$1.51M
Shares Held After
20,294
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,033
Price
$547.00
Total Value
$565.05K
Shares Held After
23,043
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,129
Price
$545.89
Total Value
$616.31K
Shares Held After
24,076
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,545
Price
$544.94
Total Value
$841.94K
Shares Held After
25,205
% of Holdings
5.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,086
Price
$544.11
Total Value
$590.91K
Shares Held After
26,750
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$542.78
Total Value
$238.82K
Shares Held After
27,836
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$541.14
Total Value
$259.75K
Shares Held After
28,276
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$539.64
Total Value
$64.76K
Shares Held After
28,756
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
HALKUFF DAWN — Director
Shares
20,000
Price
$6.09
Total Value
$121.89K
Shares Held After
95,000
% of Holdings
17.4%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
4,104
Price
$34.67
Total Value
$142.29K
Shares Held After
211,930
% of Holdings
1.9%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
25,896
Price
$34.01
Total Value
$880.72K
Shares Held After
216,034
% of Holdings
10.7%
Xeris Biopharma Holdings, Inc. (XERS)
JOHNSON JOHN — Director
Shares
15,000
Price
$6.09
Total Value
$91.42K
Shares Held After
683,083
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$550.46
Total Value
$308.26K
Shares Held After
40,513
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$549.24
Total Value
$428.41K
Shares Held After
41,073
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,676
Price
$548.26
Total Value
$918.89K
Shares Held After
41,853
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,525
Price
$547.53
Total Value
$834.98K
Shares Held After
43,529
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$546.14
Total Value
$656.46K
Shares Held After
45,054
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,186
Price
$545.18
Total Value
$646.59K
Shares Held After
46,256
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,470
Price
$544.24
Total Value
$800.04K
Shares Held After
47,442
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
396
Price
$543.11
Total Value
$215.07K
Shares Held After
48,912
% of Holdings
0.8%
Showing 7051–7100 of 26583 transactions (page 142 of 532)